IMMUNE-MEDIATED PERICARDITIS

This adverse event was reported 55 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED PERICARDITIS:

# Drug Count
0 PEMBROLIZUMAB 35
1 NIVOLUMAB 14
2 CARBOPLATIN 13
3 PEMETREXED DISODIUM 10
4 IPILIMUMAB 9
5 PEMETREXED 5
6 PACLITAXEL 4
7 PACLITAXEL (AIBUMIN-BOUND) 4
8 TRASTUZUMAB 4
9 AXITINIB 3
See all common drugs associated with IMMUNE-MEDIATED PERICARDITIS

IMMUNE-MEDIATED PERICARDITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PLATINUM 1 0.0019
1 SENNOSIDES A AND B 1 0.0006
2 UREA 1 0.0005
3 PEMBROLIZUMAB 35 0.0003
4 PEMETREXED DISODIUM 10 0.0003
5 IPILIMUMAB 9 0.0002
6 KETOROLAC TROMETHAMINE 1 0.0002
7 EPIRUBICIN HYDROCHLORIDE 1 0.0002
8 AXITINIB 3 0.0002
9 NIVOLUMAB 14 0.0001
See all drugs enriched for association with IMMUNE-MEDIATED PERICARDITIS